Department of Rheumatology - Centre National de Référence des Maladies Systémiques Rares Est Sud-Ouest (RESO), Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Internal Medicine and Systemic Diseases, Hôpital François Mitterrand, CHU de Dijon, Dijon, France.
Ann Rheum Dis. 2019 Jun;78(6):844-848. doi: 10.1136/annrheumdis-2019-215142. Epub 2019 Apr 15.
Musculoskeletal (MSK) diseases are expected to have a growing impact worldwide.
To analyse the worldwide burden of MSK diseases from 2000 to 2015.
Disability-adjusted life years (DALYs), which combines the years of life lost (YLLs) and the years lived with disability (YLDs), were extracted for 183 countries from the WHO Global Health Estimates Database. We analysed the median proportion of DALYS, YLLs and YLDs for MSK diseases (ICD-10: M00-M99) among the 23 WHO categories of diseases. Mixed models were built to assess temporal changes.
Worldwide, the total number of MSK DALYs increased significantly from 80,225,634.6 in 2000 to 107,885,832.6 in 2015 (p < 0.001), with the total number of MSK YLDs increasing from 77,377,709.4 to 103,817,908.4 (p = 0.0008) and MSK diseases being the second cause of YLDs worldwide. YLLs due to MSK diseases increased from 2,847,925.2 to 4,067,924.2 (p = 0.03). In 2015, the median proportion of DALYs attributed to MSK diseases was 6.66% (IQR: 5.30 - 7.88) in Europe versus 4.66% (3.98 - 5.59) in the Americas (p < 0.0001 vs Europe), 4.17% (3.14 - 6.25) in Asia (p < 0.0001), 4.14% (2.65 - 5.57) in Oceania (p = 0.0008) and 1.33% (1.03 - 1.92) in Africa (p < 0.0001). We observed a significant correlation (r = 0.85, p < 0.0001) between the proportion of MSK DALYs and the gross domestic product per capita for the year 2015.
The burden of MSK diseases increased significantly between 2000 and 2015 and is high in Europe. These results are crucial to health professionals and policy makers to implement future health plan adjustments for MSK diseases.
肌肉骨骼(MSK)疾病预计在全球范围内的影响日益增加。
分析 2000 年至 2015 年全球 MSK 疾病的负担。
从世卫组织全球卫生估计数据库中提取了 183 个国家的残疾调整生命年(DALYs),该指标结合了生命损失年(YLLs)和伤残生命年(YLDs)。我们分析了世卫组织 23 个疾病类别中 MSK 疾病(ICD-10:M00-M99)的 DALY、YLL 和 YLD 的中位数比例。采用混合模型评估时间变化。
全球范围内,MSK DALY 的总数从 2000 年的 80225634.6 显著增加到 2015 年的 107885832.6(p<0.001),MSK YLD 的总数从 77377709.4 增加到 103817908.4(p=0.0008),MSK 疾病成为全球 YLD 的第二大原因。MSK 疾病导致的 YLLs 从 2847925.2 增加到 4067924.2(p=0.03)。2015 年,欧洲 MSK 疾病占 DALY 的中位数比例为 6.66%(IQR:5.30-7.88),而美洲为 4.66%(3.98-5.59)(p<0.0001 与欧洲相比),亚洲为 4.17%(3.14-6.25)(p<0.0001),大洋洲为 4.14%(2.65-5.57)(p=0.0008),非洲为 1.33%(1.03-1.92)(p<0.0001)。我们观察到 2015 年 MSK DALY 比例与人均国内生产总值之间存在显著相关性(r=0.85,p<0.0001)。
2000 年至 2015 年间,MSK 疾病的负担显著增加,在欧洲尤为严重。这些结果对于卫生专业人员和政策制定者来说至关重要,他们需要为 MSK 疾病制定未来的卫生计划调整。